Used primarily in organic synthesis as a building block for pharmaceuticals and bioactive compounds, this compound serves as a key intermediate in Suzuki-Miyaura cross-coupling reactions. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of drug candidates targeting central nervous system disorders and oncology. The tetrahydroisoquinoline scaffold is commonly found in compounds with neurological activity, and the presence of the boronic acid derivative allows for rapid structural diversification during medicinal chemistry research. It is especially useful in library synthesis for high-throughput screening in drug discovery programs.